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An efficient synthesis of linear β-(1→6)-galactan oligosaccharides 
related to plant cell wall glycans 
Mathias C. F. Andersen, Camilla A. S. Arentoft, Irene Boos, Christine Kinnaert, Shahid 
I. Awan, Mads H. Clausen* 
Center for Nanomedicine and Theranostics, Department of Chemistry, Technical University of 
Denmark, Kemitorvet, Building 207, 2800 Kgs. Lyngby, Denmark. 
Abstract:  
Galactans are linear structures mainly found in arabinogalactan glycans and RG-I side chains. As a 
follow-up to our work on both β-(1→3)-linked and β-(1→4)-linked galactans, we herein report a 
convergent synthesis of β-(1→6)-galactan using our previously synthesized 4,6-benzylidene 
protected disaccharide as a key building block. However, the regioselective reductive opening of the 
4,6-benzylidene protected disaccharide turned out to become more challenging as the length of the 
oligosaccharide increased and a second differential protected disaccharide building block carrying a 
chloroacetyl group on the 6-position was used to elongate the chain in a more efficient way. 
Keywords: 
Plant cell wall oligosaccharides, Arabinogalactans, RG-I, β-(1→6)-D-galactans. 
Introduction: 
β-(1→6)-D-galactans are linear structures mainly found in arabinogalactan (AG) glycans. The latter 
are cell wall polysaccharides widely distributed in the plant kingdom and contain high proportions of 
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galactose and arabinose. They are present in many plants both as hemicellulose and arabinogalactans 
proteins.1 Due to their structural complexity and developmental origin, they are usually divided into 
two main groups: type I and type II.2 Type I AGs are characterized by a linear β-(1→4)-linked D-Galp 
chain, which may be substituted with single L-Araf, short arabinan oligosaccharide, or with β-(1→6)-
linked Galp residues. Type II AGs are highly branched polysaccharides composed of a β-(1→3) or 
(1→6)-linked-D-galactan backbone often substituted at C-3 and/or C-6 with β-galactan or 
arabinogalactan chains.3 Type II AGs make up the carbohydrate part of arabinogalactan proteins. 
Unlike the other β-galactans, linear and branched (1→6)-linked galactans have been prepared via a 
wide range of strategies. The first synthesis of a tetrameric arabinogalactan with a β-(1→6)-linked 
backbone was achieved in 1998 by van Boom and co-workers, based on the use of 1,2-anhydrosugar 
building blocks.4 Kong and colleagues later reported several syntheses of well-defined 
arabinogalactans carrying different lengths of arabinan side chain.5–10 The strategy was based on 
block synthesis, which allowed for the consecutive couplings of two tetrasaccharide building blocks. 
Later, the groups of Yang and Zhang developed one-pot glycosylation strategies for the synthesis of 
3,6-branched tetra- and hexaarabinogalactans.11,12 
Following our previous work on galactans on β-(1→4)-linked and β-(1→3)-linked D-Galp,13–15 we 
herein report the synthesis of β-(1→6)-linked D-Galp using the same disaccharide 4 as a central 
building block. 
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Scheme 1: Retrosynthesis of β-(1→6)-linked linear galactans. 
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Results and Discussion: 
We envisioned to prepare three linear β-(1→6)-linked galactans 1-3 from the central disaccharide 
building block 4 as block strategies, which usually enables the synthesis of longer chains in a better 
overall yield by decreasing the number of critical glycosylations steps (see Scheme 1).  
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Scheme 2: Synthesis of mono- and disaccharide building blocks. 
An esterification of the diol 613 with pivaloyl chloride in the presence of 0.5 equiv. of DMAP afforded 
the fully protected galactoside 5 (Scheme 2). As previously reported by Jiang and co-workers,16 only 
the 3-position was protected if the reaction was carried out at 22 ˚C and with 0.1 equiv. of DMAP. 
The obtained thioglycoside 5 was then hydrolyzed using NBS/H2O/2,6-lutidine and further converted 
into the corresponding trifluoroacetimidate donor 7 by treatment with PTFAICl and Cs2CO3.17 
Regioselective reductive opening of thioglycoside 5 with BH3·THF and Cu(OTf)2 afforded the 
desired 6-OH acceptor in 90% yield.18 TMSOTf-promoted glycosylation between 
trifluoroacetimidate donor 7 and acceptor 8 gave building block disaccharide 4 in 91% yield. It was 
crucial to perform the reaction at -40 °C to achieve good stereoselectivity. 
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Scheme 3: First attempt to synthesize β-(1→6)-linked tetrasaccharide. 
The next step was to convert thioglycoside 4 to a reducing end 6-OH acceptor (Scheme 3). Therefore, 
an NIS-TESOTf promoted glycosylation of benzyl alcohol with 4 was performed to afford reducing 
end disaccharide 9 in 86% yield. However, the following regioselective opening of the benzylidene 
acetal turned out to be more challenging than expected. Mostly hydrolysis of the glycosidic linkage 
was observed when using the same conditions as previously (Cu(OTf)2/BH3·THF), and the desired 
alcohol 10 was isolated in only 35% yield. Similar results were obtained after treatment with 
PhBCl2/Et3SiH at -78 ºC.19 Finally, treatment with Bu2BOTf/BH3·THF succeeded in affording 
disaccharide acceptor 10 in 79% yield.20,21 However, the reaction still gave rise to hydrolysis. It was 
believed that it would become harder to avoid this side-reaction when performing the same step on 
longer galactan chains as the number of glycosidic linkages that could potentially be hydrolyzed 
would increase with the length of the galactan. Therefore, it was decided to change the strategy.  
The C6-OH of thioglycoside 8 was protected with a chloroacetyl group to give thioglycoside 12 
(Scheme 4). Hydrolysis with NBS in wet acetone afforded the hemiacetal, which was converted to 
the trifluoroacetimidate donor 13 and coupled to thioglycoside 8 in a TMSOTf-promoted 
glycosylation. The reaction was slow compared to the glycosylation with benzylidene acetal-
protected trifluoroacetimidate donor 7; nevertheless, disaccharide 14 was isolated in 90% yield as a 
single stereoisomer. The reducing end acceptor 10 could now be prepared without problems by 
NIS/TESOTf-mediated glycosylation of benzyl alcohol and disaccharide 14 affording fully protected 
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disaccharide 15. Further, deprotection of the chloroacetyl group with thiourea, NaHCO3, and TBAI 
furnished the disaccharide acceptor 10 in 86% yield. 
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Scheme 4: Synthesis of chloroacetyl-protected building blocks. 
NIS/TESOTf-promoted glycosylation of disaccharide acceptor 10 with disaccharide donor 14 gave 
the tetrasaccharide 1 in 87% yield (Scheme 5). The chloroacetyl group was then selectively removed 
to give acceptor 16. The following NIS/TESOTf-promoted glycosylation of 16 with donor 14 gave 
hexasaccharide 2 in 91% yield. Repeating the two last steps once again afforded the fully protected 
octasaccharide 3 in 73% yield over two steps. The yield and reaction time were very similar in the 
three glycosylations.  
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Scheme 5: Synthesis of linear β-(1→6)-galactans. 
Global deprotection of tetrasaccharide 11 was achieved in two steps (Scheme 6). First, the pivaloyl 
groups were removed with Et4NOH, then hydrogenolysis over Pd/C gave the fully unprotected 
tetrasaccharide 19 in 72% overall yield.  
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Scheme 6: Deprotection of tetrasaccharide 11. 
Conclusion: 
A convergent synthetic strategy for β-(1→6)-D-galactans was developed using a key building 
block 14. Linear galactans up to an octasaccharide were prepared, and it is likely that much longer 
oligosaccharides can be reached with this protecting group pattern since the reactivity of the 
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consecutive glycosylations was similar. These well-defined glycans together with our previously 
synthesized β-(1→4)- and β-(1→3)-D-galactans can help to elucidate the structure and function of 
arabinogalactan proteins.  
Experimental: 
General Information: 
Starting material, reagents and solvents were purchased from commercial suppliers and were used 
without further purification. All solvents are HPLC-grade. Anhydrous solvents were obtained from 
Innovative Technology PS-MD-7 Pure-solv solvent purification system. All of the reactions were 
carried out in flame-dried glassware under an inert atmosphere. Thin-layer chromatography (TLC) 
was performed on Merck aluminium sheets pre-coated with silica, C-60 F254 plates. Compounds 
were visualized by charring after dipping in CAM stain (Ce(SO4)2 (1.6 g) and (NH4)6Mo7O24 (4 g) in 
10 % sulfuric acid (200 mL). Eluent systems are specified for each Rf value, and ratios are given as 
volume ratios.  
Evaporation of solvents was performed with a VWR International Laborota 400 under reduced 
pressure (in vacuo) at temperatures ranging between 35 - 55 °C. Traces of solvent were removed 
under reduced pressure using an oil pump. Flash chromatography was performed using Matrex 60 Å 
silica gel (35-70 μm) as the stationary phase by the general procedure developed by Still et al. The 
eluent system is specified in the protocol reported for each synthesis. Eluent ratios are given as 
volume ratios.  
NMR-spectra were recorded on a Bruker Ascend 400, Bruker Avance 800 MHz, Varian Mercury 300 
B, Bruker DQX 400 and Bruker AC 500 spectrometers. Chemical shifts (δ) are reported in ppm 
downfield from TMS (δ = 0) using solvent resonance as the internal standard. The spectra were recorded 
in CDCl3, CD3OD, D2O or DMSO-d6. 
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IR analyses were performed on a Bruker Alpha-P FT-IR instrument where solid compounds are 
applied directly to the instrument. Optical rotations were measured on a Perkin-Elmer Model 241 
Polarimeter. The solvents used were either CHCl3 or H2O.  
Melting points were measured on a Stuart melting point SMP30 and reported in °C uncorrected.  
UPLC/MS analysis was performed on a Waters AQUITY UPLC system equipped with PDA and 
SQD MS detector. Column: AQUITY UPLC BEH C18 1.7μm, 2.1 x 50mm. Column temp: 65 ˚C. 
Flow rate: 0.6 ml/min. Solvent A: 0.1% formic acid in water, Solvent B: 0.1% formic in MeCN. 
Gradient: 5% B to 100% B in 2.4 min, hold 0.1 min, total run time 2.6 min. High-resolution LC-
DAD-MS was performed on an Agilent 1100 system equipped with a photodiode array detector 
(DAD) and coupled to an LCT orthogonal time-of-flight mass spectrometer (Waters-Micromass, 
Manchester, UK) with Z-spray electrospray ionization (ESI) source and a LockSpray probe and 
controlled MassLynx 4.0 software. LC-MS calibration from m/z 100-900 was done with a PEG 
mixture. Standard separation involved a LUNA 2 column with a MeCN (50 ppm TFA) in water 
gradient starting from 15% to 100% over 25 minutes with a flow rate of 0.3 mL/min. 
Spectroscopic data is not given for N-phenyl trifluoroacetimidates due to their low stability. 
Experimental Procedures: 
Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (5) 
Compound 6 (10 g; 27.74 mmol) was dissolved in CH2Cl2 (250 mL). Et3N (15.5 mL; 110.98 mmol), 
DMAP (1.70 g; 13.87 mmol) and pivaloyl chloride (9.4 mL; 110.98 mmol) were added to the solution 
and the reaction mixture was heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (20 mL), washed with water (2x200 mL), dried over MgSO4 and concentrated. 
The product was purified by flash chromatography (toluene/EtOAc 19:1) to afford 5 as a white 
amorphous powder. Rf 0.58 (9:1 toluene/EtOAc). Yield 13.79 g (94%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= 18.6° (c 1.0, CDCl3). 
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IR (neat, cm-1): 3062, 2972, 2933, 2906, 2872, 1732, 1584, 1479, 1457, 1397, 1367, 1281, 1157, 
1139, 1092, 1045, 1026. 1H NMR (400 MHz, CDCl3) δ 7.52 – 7.47 (m, 2H, Ar-H), 7.31 (m, 8H, Ar-
H), 5.42 (s, 1H, -CHbenzylidene), 5.36 (t, J1,2 = J2,3 = 9.9 Hz, 1H, H-2), 4.88 (dd, J2,3 = 9.9, J3,4 = 3.5 Hz, 
1H, H-3), 4.66 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.33 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.31 (dd, J6a,6b = 12.4, J5,6z 
= 1.1 Hz, 1H, H-6a), 3.95 (dd, J6a,6b = 12.4, J5,6b = 1.7 Hz, 1H, H-6b), 3.52 (m, 1H, H-5), 1.14 (s, 9H, 
3xCH3Piv), 1.04 (s, 9H, 3xCH3Piv). 13C NMR   (101 MHz, CDCl3) δ 178.2, 176.2, 137.7, 133.1 (2C), 
131.9, 129.0, 128.8 (2C), 128.1 (2C), 128.0, 126.2 (2C), 100.6, 85.7, 73.3, 73.1, 69.7, 69.2, 65.9, 
39.0, 38.8, 27.2 (3C), 27.0 (3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C29H36NaO7S 
551.2079; Found 551.2071. 
4,6-O-Benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (7) 
Compound 5 (10.0 g; 18.91 mmol) was dissolved in MeCN (250 mL) and water (25 mL). NBS 
(13.5 g; 75.66 mmol) was added, and the reaction was stirred at 50 °C for 4 h. The solution was 
diluted with EtOAc (500 mL) and washed with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 
(200 mL). The organic phase was dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (4:1 toluene/EtOAc) to afford the corresponding hemiacetal.  
Rf 0.17 (4:1 toluene/EtOAc). Further, this hemiacetal was dissolved in CH2Cl2 (200 mL) and cooled 
to 0 °C. Cs2CO3 (11.9 g; 36.65 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride 
(7.6 g; 36.65 mmol). The ice bath was removed, and the reaction mixture was stirred for 12 h. It was 
then filtered, through a plug of Celite, concentrated and purified by flash chromatography (9:1 
toluene/EtOAc) to give 352 as a white amorphous product. Yield: 6.9 g (62% over two steps). 
Phenyl 4-O-benzyl-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (8) 
A 1 M solution of BH3.THF complex in THF (189.2 mL) was added to a solution of 5 (20 g; 
37.8 mmol) in DCM (100 mL) at 0 °C. The mixture was stirred for 10 min, and freshly dried Cu(OTf)2 
(2.1 g, 5.67 mmol) was added to the solution. After stirring for a 5 h, the mixture was cooled to 0 °C, 
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and the reaction was quenched by addition of triethylamine (5.3 mL, 37.8 mmol) and methanol 
(69 mL, caution: hydrogen gas was evolved). The resultant mixture was concentrated at reduced 
pressure followed by coevaporation with methanol. The residue was purified by flash column 
chroma-tography (9:1 toluene/EtOAc) to afford 8 as a slightly yellow amorphous material.  
Rf 0.21 (9:1 toluene/EtOAc). Yield: 18.1 g (90%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= 2.2° (c 1.0, CDCl3). IR (neat, cm-1): 3522, 
3062, 3032, 2970, 2934, 2906, 2872, 1733, 1479, 1457, 1397, 1365, 1279, 1162, 1138, 1082, 1041.  
1H NMR (400 MHz, CDCl3) δ 7.42 – 7.35 (m, 2H, Ar-H), 7.32 – 7.14 (m, 8H, Ar-H), 5.42 (t, J1,2 = 
J2,3 = 9.9 Hz, 1H, H-2), 5.01 (dd, J2,3 = 9.9, J3,4 = 2.9 Hz, 1H, H-3), 4.74 (d, JCH2 = 11.3 Hz, 1H, 
0.5xCH2Bn), 4.64 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.39 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2Bn), 3.89 (d, J3,4 = 
2.9 Hz, 1H, H-4), 3.76 (dd, J6a,6b = 11.2, J5,6a =6.9 Hz, 1H, H-6a), 3.61 – 3.53 (dd, J5,6a =6.9, J5,6b 
=5.2 Hz, 1H), 3.47 (dd, J6a,6b =11.2, J5,6b =5.2 Hz, 1H, H-6b), 1.14 (s, 9H, 3xCH3Piv), 1.11 (s, 9H, 
3xCH3Piv). 13C NMR   (101 MHz, CDCl3) δ 177.7, 176.5, 137.5, 132.9, 131.9 (2C), 128.9 (2C), 128.5 
(2C), 128.0, 127.8 (2C), 127.7, 86.7, 78.8, 75.1, 74.8, 74.2, 67.4, 61.8, 38.9, 38.7, 27.2 (3C), 27.2 
(3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C29H38NaO7S 553.2236; Found 553.2231. 
Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-1-thio-galactopyranoside (4)  
To a 250 mL flame-dried flask was added 8 (4.7 g, 8.76 mmol) and the 7 (6.4 g, 10.50 mmol). The 
mixture was co-evaporated with toluene (2x100 mL) and subjected to vacuum overnight. The mixture 
dissolved in CH2Cl2 (100 mL) and cooled to -40 °C. TMSOTf (0.20 mL; 0.88 mmol) was added and 
the reaction mixture was stirred at -40 °C for 1.5h. Et3N (1 mL) was added and the reaction mixture 
was concentrated. The crude compound was purified by flash chromatography (19:1 toluene/EtOAc) 
to afford 4. Rf 0.52 (9:1 toluene/EtOAc). Yield: 7.6 g (91%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= 11.4° (c 1.0, CDCl3). 1H NMR 
(400 MHz, CDCl3) δ 7.44 – 7.34 (m, 4H, HSPh), 7.29 – 7.13 (m, 11H, HSPh. Ar-H), 5.43 (s, 
1H, -CHbenzylidene), 5.38 (t, J1,2 = J2,3 =9.8 Hz, 1H, H-2), 5.33 (dd, J2,3 = 9.7, J1,2 =8.0 Hz, 1H, H-2’), 
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5.02 (dd, J2,3 = 9.8, J3,4 = 2.9 Hz, 1H, H-3), 4.79 (dd, J2,3 = 9.7, J3,4 = 3.7 Hz, 1H, H-3’), 4.68 (d, JCH2 
= 11.2 Hz, 1H, -CH2Bn), 4.59 (d, J = 9.8 Hz, 1H, H-1), 4.55 (d, JCH2 = 11.2 Hz, 1H, -CH2Bn), 4.45 (d, 
J = 8.0 Hz, 1H, H-1’), 4.33 – 4.28 (m, 1H, H-4’), 4.22 – 4.15 (m, 1H, H-6a’), 3.95 (dd, J = 12.5, 1.9 
Hz, 1H, H-6b’), 3.86 (m, 2H, H-4, H-6a), 3.75 – 3.63 (m, 2H, H-6b, H-5), 3.39 – 3.35 (m, 1H, H-5’), 
1.13 (s, 9H, 3xCH3Piv), 1.09 (s, 9H, 3xCH3Piv), 1.07 (s, 9H, 3xCH3Piv), 1.07 (s, 9H, 3xCH3Piv). 13C 
NMR   (101 MHz, CDCl3) δ 178.1, 177.4, 176.5, 176.4, 138.1, 137.5, 132.8, 132.1 (2C), 128.9 (2C), 
128.8, 128.2 (2C), 128.0 (2C), 127.7, 127.5 (2C), 127.4, 125.9 (2C), 100.7, 100.5, 86.4, 77.6, 74.9, 
74.6, 74.5, 73.0, 71.8, 68.7, 68.1, 67.3, 66.9, 66.4, 38.9, 38.8, 38.7, 27.2, 27.2 (3C), 27.1 (3C), 27.1 
(3C), 27.0 (3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C52H58NaO14S: 971.4228; Found 
971.4229. 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranoside (9) 
Compound 4 (2.0 g; 2.11 mmol) was dried azeotropically with toluene (2x30 mL) and left under 
vacuum over night. Freshly distilled benzyl alcohol (0.26 mL; 2.52 mmol) was added and the mixture 
was dissolved in dry CH2Cl2 (30 mL) and cooled to -40 °C. Then NIS (497 mg; 2.21 mmol) and 
TESOTf (45 μL; 0.21 mmol) were added and the reaction mixture was stirred at -40 °C until TLC 
revealed full conversion of the donor (4 h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. Na2SO3 (50 mL) and sat. aq. NaHCO3 (50 mL), dried over MgSO4 and 
concentrated. The product was purified by flash chromatography (4:1 Heptan/EtOAc) to yield a white 
amorphous solid. Rf 0.35 (9:1 toluene/EtOAc). Yield: 1.7 g (86 %). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= 24.6° (c 1.0, CDCl3). 1H 
NMR (400 MHz, CDCl3) δ 7.41 (m, 2H, HBn),  7.35 – 7.13 (m, 13H, HBn, Ar-H), 5.45 (s, 1H, -
CHbenzylidene), 5.42 (dd, J2,3 = 10.6, J1,2 = 8.1 Hz, 1H, H-2), 5.37 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-
2’), 4.96 (dd, J2,3 = 10.6, J3,4 = 3.1 Hz, 1H, H-3), 4.82 (dd, J2,3 =  10.4, J3,4 = 3.8 Hz, 1H, H-3’), 4.77 
(d, JCH2 = 12.0 Hz, 1H, CH2a), 4.70 (d, JCH2 = 11.2 Hz, 1H, CH2b), 4.55 (d, JCH2 = 11.2 Hz, 1H, CH2a), 
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4.49 (d, JCH2 = 12.0 Hz, 1H, CH2a), 4.48 (d, J = 7.9 Hz, 1H, H-1’), 4.42 (d, J = 7.9 Hz, 1H, H-1), 4.32 
(dd, J3,4 = 3.8, J4,5 = 1.0 Hz, 1H, H-4’), 4.20 (dd, J6a,6b = 12.5, J5,6a = 1.6 Hz, 1H, H-6a’), 3.97 (dd, 
J6a,6b = 12.5, J5,6b 1.8 Hz, 1H, H-6b’), 3.89 (dd, J = 9.8, 5.9 Hz, 1H, H-6a), 3.85 (d, J3,4 = 3.0 Hz, 1H, 
H-4), 3.73 – 3.62 (m, 1H, H-5, H-6b), 3.41 – 3.37 (m, 1H, H-5’), 1.11 (s, 9H, 3x-CH3Piv), 1.09 (s, 
18H, 6x-CH3Piv), 1.04 (s, 9H, 3x-CH3Piv). 13C NMR   (101 MHz, CDCl3) δ 178.1, 177.6, 176.7, 176.5, 
138.0, 137.5, 137.0, 128.8, 128.2 (4C), 128.0 (2C), 127.8 (2C), 127.7 (2C), 127.6, 127.5, 125.9 (2C), 
100.8, 100.5, 100.1, 77.2, 75.1, 74.7, 73.8, 73.5, 73.0, 71.9, 70.3, 69.3, 68.7, 68.1, 66.9, 66.4, 38.9, 
38.9, 38.7, 38.7, 27.2 (3C), 27.1 (3C), 27.1 (3C), 27.0 (3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd 
for C53H70NaO15 969.4612; Found 969.4614. 
Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranoside (10) 
A solution of 1 M BH3 in THF (10 mL) was added to a 50 ml dry flask containing l mmol of 
compound 9 at 0 °C, and the solution was stirred for 5 minutes. A solution of 1 M Bu2BOTf in CH2Cl2 
(1 mL) was then added to the clear solution slowly. After 1 hour at 0 °C, TLC showed that the starting 
material had disappeared. Triethylamine (0.5 mL) was added followed by careful addition of 
methanol until the evolution of H2 had ceased. The reaction mixture was co-distilled with methanol 
three times after which the product was purified by flash chromatography (9:1 toluene/EtOAc) to 
afford 10 as a colorless amorphous material. Yield: 749 mg (79%). 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl- 
(1→6)- 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (11) 
To a 25 mL flame-dried flask was added 10 (500 mg, 0.53 mmol) and 4 (658 mg, 2.05 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and subjected to vacuum overnight. It was 
then dissolved in dry CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled to -30 °C, followed by addition 
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of NIS (157 mg; 0.70 mmol) and TESOTf (14 mg; 0.05 mmol). The reaction mixture was stirred 
at -30 °C until TLC revealed full conversion of the donor (1.5h). The solution was diluted with CH2Cl2 
(100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (9:1 toluene/EtOAc) to afford 11 as a white amorphous material. Rf 0.45 (9:1 
toluene/EtOAc).Yield: 792 mg (81%). 1H NMR (400 MHz, CDCl3) δ 7.52 – 7.01 (m, 35H), 5.44 (s, 
1H, CHbenzylidene), 5.42 (dd, J2,3 = 10.1, J1,2 = 8.7 Hz, 1H, H-2), 5.37 (dd, J2,3 = 10.2, J1,2 = 8.0 Hz, 1H, 
H-2), 5.30 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.29 (dd, J2,3 = 10.7, J1,2 = 8.0 Hz, 1H, H-2), 4.99 
(dd, J2,3 = 10.6, J3,4 = 2.8 Hz, 1H, H-3), 4.96 (dd, J2,3 = 10.3, J3,4 = 2.7 Hz, 1H, H-3), 4.94 (dd, J2,3 = 
10.3, J3,4 = 2.9 Hz, 1H, H-3), 4.82 (dd, J2,3 = 10.3, J3,4 = 3.7 Hz, 1H, H-3), 4.76 (d, JCH2 = 12.0 Hz, 
1H, 0.5xCH2Bn), 4.70 – 4.45 (m, 7H, 3.5xCH2Bn), 4.41 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.36 (d, J1,2 = 8.0 
Hz, 1H, H-1), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.32 (d, J3,4 = 3.1 Hz, 1H), 4.29 (d, J1,2 = 7.9 Hz, 1H, 
H-1), 4.14 (d, J = 11.8 Hz, 1H, 0.5xH-6), 4.01 – 3.77 (m, 8H, 3xH-4, 2.5xH-6), 3.72 – 3.32 (m, 5H, 
4xH-5, H-6), 1.11 – 1.02 (m, 72H, 24xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 178.2, 177.6, 177.5, 
177.5, 176.8 (2C), 176.8, 176.6, 138.5, 138.4, 138.2, 137.7, 137.0, 128.9-126.0 (35C), 101.2, 101.1, 
100.9, 100.6, 100.0, 75.4, 75.2, 75.1, 74.7, 74.5, 74.4, 73.9, 73.7, 73.6, 73.5, 73.1, 73.0, 72.0, 71.9, 
70.4, 70.3, 69.7, 69.4, 68.8, 68.7, 68.2, 67.0, 67.0, 66.5, 66.5, 66.1, 66.0, 39.0 (2C), 38.9 (2C), 38.8 
(2C), 38.8 (2C), 27.3 (3C), 27.3 (6C), 27.3 (3C), 27.2 (3C), 27.2 (6C), 27.1 (3C). 
Phenyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (12) 
Compound 8 (30.0 g; 56.53 mmol) was dissolved in CH2Cl2 (560 mL) and cooled to 0 °C. (ClAc)2O 
(15.0 g; 87.62 mmol), Et3N (12.7 mL; 90.45 mmol) and DMAP (138 mg; 1.13 mmol) was added and 
the reaction was stirred at 0 °C for 1 h. The reaction mixture was concentrated and purified by flash 
chromatography (20:1 toluene/EtOAc) to afford 12 as a yellowish amorphous powder. Rf 0.57 (9:1 
toluene/EtOAc). Yield 30.2 g (88%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -6.7° (c 1.0, CDCl3). 1H NMR (400 MHz, CDCl3) δ 
14 
 
7.45 – 7.33 (m, 2H, HSPh), 7.31 – 7.11 (m, 8H, HSPh, HBn), 5.41 (t, J1,2 = J2,3 =9.9 Hz, 1H, H-2), 5.02 
(dd, J2,3 = 9.9, J3,4 = 2.9 Hz, 1H, H-3), 4.78 (d, JCH2 = 11.4 Hz, 1H, -CH2Bn), 4.62 (d, J1,2 = 9.9 Hz, 
1H, H-1), 4.38 (d, JCH2 = 11.4 Hz, 1H, -CH2Bn), 4.29 (dd, J6a,6b = 11.2, J5,6a = 6.9 Hz, 1H, H-6a), 4.04 
(dd, J6a,6b = 11.2, J5,6b = 5.8 Hz, 1H, H-6b), 3.98 – 3.80 (m, 3H, -CH2AcCl, H-4), 3.73 (ddd, J5,6a = 6.9, 
J5,6b = 5.8, J4,5 = 1.2 Hz, 1H, H-5), 1.15 (s, 9H, 3xCH3Piv), 1.13 (s, 9H, 3xCH3Piv). 13C NMR 
(101 MHz, CDCl3) δ 177.8, 176.6, 166.8, 137.4, 133.0, 132.4 (2C), 128.9 (2C), 128.6 (2C), 128.1, 
128.0 (2C), 128.0, 87.0, 75.6, 74.9, 74.9, 73.9, 67.3, 64.3, 40.6, 39.1, 38.9, 27.3 (3C), 27.3 (3C). 
HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C31H40ClNaO8S 630.2030; Found  630.2030. 
4-O-Benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranose N-phenyl 
trifluoroacetimidate (13) 
Compound 12 (20.0 g; 32.94 mmol) was dissolved in acetone (330 mL) and water (30 mL). NBS 
(14.8 g; 65.88 mmol) was added, and the reaction was stirred at 22 °C for 3 h. The solution was 
diluted with EtOAc (500 mL) and washed with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 
mL). The organic phase was dried over MgSO4, filtered and concentrated. The residue was purified 
by flash chromatography (4:1 toluene/EtOAc) to afford 13. Rf 0.19 (4:1 toluene/EtOAc) Yield: 14.9 
g (88%). Hemiacetal (14.9 g; 28.88 mmol) was dissolved in CH2Cl2 (300 mL) and cooled to 0 °C. 
Cs2CO3 (18.8 g; 57.75 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride (12.0 g; 
57.75 mmol). The ice bath was removed, and the reaction mixture was stirred for 12 h. It was then 
filtered, through a plug of Celite, concentrated and purified by flash chromatography (15:1 
toluene/EtOAc) to give 13 as a white amorphous product. Yield:  15.5 g (78%). 
Phenyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (14) 
To a 500 mL flame-dried flask was added 8 (7.2 g, 13.56 mmol) and 13 (11.2 g, 16.28 mmol). The 
mixture was co-evaporated with toluene (2x200 mL) and subjected to vacuum overnight. The mixture 
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dissolved in CH2Cl2 (200 mL) and cooled to -40 °C. TMSOTf (0.23 mL; 1.35 mmol) was added, and 
the reaction mixture was stirred at -40 °C for 2h. Et3N (1 mL) was added, and the reaction mixture 
was concentrated. The crude compound was purified by flash chromatography (9:1 toluene/EtOAc) 
affording 14. Rf 0.5 (4:1 toluene/EtOAc). Yield: 12.5 g (90%).  
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (15) 
Compound 14 (3.0 g; 2.92 mmol) was dried azeotropically with toluene (2x50 mL) and subjected to 
vacuum overnight. Benzyl alcohol (378 mg; 3.50 mmol) was added. The mixture was dissolved in 
dry CH2Cl2 (50 mL) and cooled to -40 °C. NIS (689 mg; 3.06 mmol) and TESOTf (77 mg; 0.29 
mmol) was added and the reaction mixture was stirred at -40 °C until TLC revealed full conversion 
of the donor (4 h). The solution was diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 
(100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (19:1 toluene/EtOAc) to afford 15 
as a white amorphous material. Rf 0.49 (9:1 toluene/EtOAc). Yield: 2.60 g (87%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -14.3° (c 
1.0, CDCl3). IR (neat, cm-1): 3064, 3031, 2971, 2935, 2906, 2872, 1734, 1496, 1479, 1456, 1397, 
1366, 1278, 1141, 1073, 1041. 1H NMR (400 MHz, CDCl3) δ 7.48 – 6.88 (m, 15H, Ar-H), 5.40 (dd, 
J2,3 = 10.4, J1,2 =7.9 Hz, 1H, H-2), 5.35 (dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-2’), 4.95 (dd, J2,3 = 10.4, 
J3,4 = 3.0 Hz, 1H, H-3’), 4.94 (dd, J2,3 = 10.4, J3,4 = 3.1 Hz, 1H, H-3), 4.80 (d, JCH2 = 11.8 Hz, 1H, 
0.5xCH2Bn), 4.77 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2Bn), 4.70 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2Bn), 4.48 
(d, JCH2 = 11.6 Hz, 1H, 0.5xCH2Bn), 4.42 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.38 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2Bn), 4.39 (d, J1,2 = 7.8 Hz, 1H, H-1’), 4.15 (dd, J6a,6b = 11.1, J5,6a = 6.4 Hz, 1H, H-6a’), 4.02 
(dd, J6a,6b = 11.1, J5,6b = 6.5 Hz, 1H, H-6b’), 3.88 – 3.78 (m, 5H, H-4, H-4’, H-6a, CH2AcCl), 3.68 – 
3.54 (m, 3H, H-5, H-5’, H-6b), 1.15 (s, 9H, 3xCH3Piv), 1.11 (s, 9H, 3xCH3Piv), 1.09 (s, 9H, 3xCH3Piv), 
1.04 (s, 9H, 3xCH3Piv). 13C NMR   (101 MHz, CDCl3) δ 177.9, 177.7, 176.8, 176.7, 166.8, 138.0, 
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137.3, 137.0, 128.6 (2C), 128.4 (2C), 128.3 (2C), 128.2 (2C), 128.2, 127.9 (2C), 127.8 (2C), 127.8 
(2C), 101.3, 100.1, 75.2, 75.1, 74.7, 73.8, 73.7 (2C), 73.5, 71.9, 70.3, 69.3, 69.3, 67.5, 63.8, 40.6, 
39.1, 39.0, 38.9, 38.8, 27.3 (3C), 27.3 (3C), 27.3 (3C), 27.2 (3C). HRMS (ESI-TOF) m/z: [M + Na]+ 
Calcd for C55H73ClNaO16 1047.4485; Found 1047.4484. 
Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranoside (10) 
Compound 9 (2.9 g; 2.83 mmol) was dissolved in dry THF (50 mL). Thiourea (645 mg; 8.48 mmol), 
Bu4NI (209 mg; 0.57 mmol) and NaHCO3 (784 mg; 9.33 mmol) were added and the reaction mixture 
was heated to 55 °C for 6 h. The mixture was filtered, concentrated and purified by flash 
chromatography (9:1 toluene/EtOAc). Rf 0.22 (9:1 toluene/EtOAc). Yield: 2.39 g (89%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -
8.0° (c 1.0, CDCl3). 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.00 (m, 15H, Ar-H), 5.40 (dd, J2,3 = 10.4, 
J1,2 = 7.9 Hz, 1H, H-2), 5.34 (dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-2’), 4.93 (dd, J2,3 = 10.4, J3,4 = 2.8 
Hz, 1H, H-3), 4.93 (dd, J2,3 = 10.4, J3,4 = 2.8 Hz, 1H, H-3’), 4.80 – 4.74 (m, 2H, CH2Bn), 4.72 (d, JCH2 
= 11.4 Hz, 1H, 0.5xCH2Bn), 4.50 (d, J = 11.3 Hz, 1H, 0.5xCH2Bn), 4.49 (d, JCH2= 12.0 Hz, 1H, 
0.5xCH2Bn), 4.41 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 4.33 (d, J1,2 = 
7.9 Hz, 1H, H-1’), 3.87 (d, J3,4 = 2.8 Hz, 1H, H-4’), 3.85 (d, J3,4 = 2.8 Hz, 1H, H-4), 3.83 – 3.77 (m, 
1H, H-6a), 3.67 – 3.56 (m, 3H, H-6b, H-6a’, H-5), 3.50 – 3.43 (m, 1H, H-5’), 3.43 – 3.34 (m, 1H, H-
6b’), 1.14 (s, 9H, 3xCH3Piv), 1.11 (s, 9H, 3xCH3Piv), 1.10 (s, 9H, 3xCH3Piv), 1.03 (s, 9H, 3xCH3Piv). 
13C NMR   (101 MHz, CDCl3) δ 176.7, 176.7, 175.7, 175.6, 137.0, 136.5, 135.8, 127.5 (2C), 127.2 
(2C), 127.2 (2C), 127.1 (2C), 126.8 (2C), 126.6 (2C), 126.6 (2C), 100.3, 98.9, 73.9, 73.9, 73.4, 73.0, 
72.8, 72.6, 72.5, 69.2, 68.3, 68.2, 66.4, 60.6, 37.9, 37.9, 37.7, 37.7, 26.2 (3C), 26.2 (3C), 26.1 (3C), 
26.1 (3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C53H72NaO15 971.4769; Found 971.4774. 
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Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (1) 
To a 100 mL flame-dried flask was added 10 (1.5 g, 1.58 mmol) and the 14 (2.11 g, 2.05 mmol). The 
mixture was dried azeotropically with toluene (2x50 mL) and subjected to vacuum overnight. It was 
then dissolved in dry CH2Cl2 (25 mL) and dry MeCN (25 mL), cooled to -30 °C, followed by addition 
of NIS (472 mg; 2.10 mmol) and TESOTf (42 mg; 0.16 mmol). The reaction mixture was stirred 
at -30 °C until TLC revealed full conversion of the donor (1.5 h). The solution was diluted with 
CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (20:1 toluene/EtOAc) to afford a white amorphous material. Rf 0.43 (9:1 
toluene/EtOAc). Yield: 2.6 g (88%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -18.8° (c 1.0, CDCl3) IR (neat, cm-1):2971, 2935, 2907, 
2872, 1733, 1479, 1456, 1397, 1365, 1278, 1132, 1070, 1042. 1H NMR (400 MHz, CDCl3) δ 7.47 – 
6.98 (m, 25H, Ar-H), 5.39 (dd, J2,3= 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.33 (dd, J2,3 = 10.3, J1,2 = 7.7 Hz, 
1H, H-2), 5.29 (dd, J2,3= 10.3, J1,2 = 7.7 Hz, 1H, H-2), 5.28 (dd, J2,3= 10.4, J1,2 = 7.8 Hz, 1H, H-2), 
5.01 – 4.90 (m, 4H, H-31-H-34), 4.79 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 4.76 (d, JCH2 = 12.0 Hz, 
1H, 0.5xCH2Bn), 4.65 (m, 3H, 1.5xCH2Bn), 4.54 (d, JCH2 = 11.0 Hz, 1H, 0.5xCH2Bn), 4.53 (d, JCH2 = 
11.1 Hz, 1H, 0.5xCH2Bn), 4.49 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2Bn), 4.48 (d, JCH2 = 12.0 Hz, 1H, 
0.5xCH2Bn), 4.40 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 
7.8 Hz, 1H, H-1), 4.29 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.29 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.09 (dd, J6a,6b = 
11.0, J5,6a = 6.2 Hz, 1H, H-6a4), 4.00 (dd, J6a,6b = 11.0, J5,6b = 6.6 Hz, 1H, H-6b4), 3.95 – 3.76 (m, 7H, 
H-41-H-44, 1.5xH-6), 3.73 (d, J = 1.5 Hz, 1H, H-54), 3.67 – 3.48 (m, 4H, H-51-H-53, 0.5xH-6), 3.42 
– 3.31 (m, 2H, H-6), 1.15 (s, 9H, 3xCH3Piv), 1.10 (s, 9H, 3xCH3Piv), 1.09 (s, 9H, 3xCH3Piv), 1.09 (s, 
9H, 3xCH3Piv), 1.08 (s, 9H, 3xCH3Piv), 1.08 (s, 18H, 6xCH3Piv), 1.03 (s, 9H, 3xCH3Piv). 13C NMR   
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(101 MHz, CDCl3) δ 177.9, 177.6, 177.5, 177.5, 176.8, 176.8, 176.8, 176.8, 166.8, 138.4, 138.3, 
138.2, 137.4, 137.0, 128.6, 128.3, 128.3, 128.3, 128.2, 127.9, 127.8, 127.7, 127.6, 127.6, 127.5, 127.4, 
101.3, 101.2, 101.1, 100.0, 77.3, 75.3, 75.2, 75.1, 75.1, 74.8, 74.5, 74.4, 73.7, 73.6, 73.5, 73.1, 73.0, 
73.0, 71.9, 70.3, 69.7, 69.7, 69.4, 69.3, 67.0, 66.4, 66.2, 63.8, 40.5, 39.1, 39.0, 38.9, 38.9, 38.9, 38.8, 
38.8, 38.8, 27.3, 27.3, 27.3, 27.3, 27.3, 27.2, 27.2, 27.2. 
Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (16) 
Compound 1 (3.1 g; 1.66 mmol) was dissolved in dry THF (50 mL). Thiourea (380 mg; 4.98 mmol), 
Bu4NI (123 mg; 0.33 mmol) and NaHCO3 (460 mg; 5.48 mmol) was added and the reaction mixture 
was heated to 55 °C for 8 h. The mixture was filtered, concentrated and purified by flash 
chromatography (9:1 toluene/EtOAc) to give 16. Rf 0.17 (9:1 toluene/ EtOAc). Yield: 2.59 g (87%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -14.8° (c 1.0, CDCl3). 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.00 (m, 25H), 5.47 – 5.20 (m, 
4H, H-21-H-24), 5.03 – 4.86 (m, 4H, H-31-H-34), 4.81 – 4.44 (m, 9H, 4.5xCH2Bn), 4.40 (d, J1,2 = 7.9 
Hz, 1H, H-11/2/3/4), 4.35 (d, J1,2 = 7.8 Hz, 1H, H-11/2/3/4), 4.28 (d, J1,2 = 7.8 Hz, 1H, H-11/2/3/4), 4.24 (d, 
J1,2 = 7.9 Hz, 1H, H-11/2/3/4), 3.94 – 3.74 (m, 8H, H-41-H-44, 2xH-6), 3.64 – 3.25 (m, 8H, H-51-H-54, 
2xH-6), 1.13 (s, 9H, 3xCH3Piv), 1.12 – 1.06 (m, 54H, 18xCH3Piv), 1.03 (s, 9H, 3xCH3Piv). 13C NMR   
(101 MHz, CDCl3) δ 177.7, 177.6, 177.5, 177.4, 176.7, 176.7 (2C), 176.7, 138.3, 138.3, 138.1, 137.5, 
136.9, 128.5, 128.2, 128.1, 128.1, 128.1, 128.0, 127.8, 127.7, 127.6, 127.5, 127.5, 127.5, 127.4, 127.4, 
101.4, 101.0, 101.0, 99.9, 77.2, 75.1, 75.0, 75.0, 75.0, 74.9, 74.6, 74.1, 73.8, 73.5, 73.4, 73.1, 73.0, 
73.0, 73.0, 70.1, 69.6, 69.5, 69.4, 69.3, 66.9, 66.4, 66.2, 61.6, 38.9, 38.9, 38.8 (2C), 38.8, 38.7 (2C), 
38.7, 27.2-27.1 (24C). 
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
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galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-dipivaloyl-β-D-
galactopyranoside (2) 
To a 100 mL flame-dried flask was added 16 (2.15 g, 1.20 mmol) and the 14 (1.60 g, 1.56 mmol). 
The mixture was dried azeotropically with toluene (2x50 mL) and subjected to vacuum overnight. It 
was then dissolved in dry CH2Cl2 (20 mL) and dry MeCN (20 mL), cooled to -30 °C, followed by 
addition of NIS (359 mg; 1.60 mmol) and TESOTf (32 mg; 0.12 mmol). The reaction mixture was 
stirred at -30 °C until TLC revealed a full conversion of the donor (1 h). The solution was diluted 
with CH2Cl2 (200 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). 
The organic phase was dried over MgSO4, filtered and concentrated. The product was purified by 
flash chromatography (20:1 toluene/EtOAc) to afford 2 as a white amorphous material. Rf 0.45 (9:1 
toluene/EtOAc). Yield: 2.95 g (91%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -11.6° (c 1.0, CDCl3). IR(neat, cm-1): 3065, 3031, 2971, 
2935, 2906, 2872, 1733, 1479, 1457, 1397, 1365, 1278, 1132, 1070. 1H NMR (400 MHz, CDCl3) δ 
7.40 – 7.00 (m, 35H), 5.48 – 5.14 (m, 6H, H-21-H-26), 5.05 – 4.88 (m, 6H, H-31-H-36), 4.79 (d, JCH2 
= 11.3 Hz, 1H, 0.5xCH2Bn), 4.76 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2Bn), 4.69 – 4.44 (m, 11H, 5.5xCH2Bn), 
4.40 (d, J1,2 = 7.9 Hz, 1H, H-11/2/3/4/5/6), 4.375 (d, J1,2 = 7.9 Hz, 1H, H-11/2/3/4/5/6), 4.37 (d, JCH2 = 11.4 
Hz, 1H, 0.5xCH2Bn), 4.35 (d, J1,2 = 7.8 Hz, 1H, H-11/2/3/4/5/6), 4.30 – 4.21 (m, 3H, H-11/2/3/4/5/6, H-
11/2/3/4/5/6, H-11/2/3/4/5/6), 4.07 (dd, J6a,6b = 11.1, J5,6a = 6.2 Hz, 1H, H-6a6), 3.99 (dd, J6a,6b =  11.1, J5,6b 
= 6.6 Hz, 1H, H-6b6), 3.94 – 3.75 (m, 11H, H-41-H-46, 2.5xH-6), 3.71 (d, JCH2 = 2.1 Hz, 2H, -CH2AcCl), 
3.68 – 3.44 (m, 8H, H-51-H-56, H-6), 3.36 (dd, J6a,6b = 9.3, J5,6a = 5.3 Hz, 1H, 0.5xH-6), 3.27 (m, 2H, 
H-6), 1.15 (s, 9H, 3xCH3Piv), 1.11 – 1.05 (m, 90H, 30xCH3Piv), 1.03 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ 177.7, 177.5, 177.4, 177.3 (2C), 177.3, 176.7 (2C), 176.7 (2C), 176.6, 166.6, 138.5 (2C), 
138.3, 138.2, 138.1, 137.2, 136.9, 128.5-127.1 (35C), 101.2, 101.1 (2C), 99.9, 77.2, 75.2, 75.1, 75.0, 
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74.6, 74.4, 74.2, 73.6, 73.5, 73.4, 73.0, 72.9, 72.8, 71.8, 70.1, 69.6, 69.6, 69.3, 69.1, 66.9, 65.8, 63.6, 
40.4-38.7 (12C), 27.2-27.1 (36C). 
Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)- 4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (17) 
Compound 2 (2.15 g; 0.79 mmol) was dissolved in dry THF (50 mL). Thiourea (241 mg; 3.18 mmol), 
Bu4NI (59 mg; 0.16 mmol) and NaHCO3 (293 mg; 3.49 mmol) was added and the reaction mixture 
was heated to 55 °C for 8 h. The mixture was filtered, concentrated and purified by flash 
chromatography (9:1 toluene/EtOAc) to afford 17 as a slightly yellow amorphous material. Rf 0.22 
(9:1 toluene/EtOAc). Yield: 1.75 g (84%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -22.5° (c 1.0, CDCl3) IR (neat, cm-1): 2971, 2935, 
2872, 1734, 1496, 1479, 1278, 1133, 1070, 1045. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.08 (m, 
35H), 5.39 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.29 (m, 5H, 5xH-2), 5.04 – 4.89 (m, 6H, 6xH-
3), 4.76 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2Bn), 4.72 – 4.45 (m, 12H, 6xCH2Bn), 4.43 – 4.19 (m, 7H, 
0.5xCH2Bn, 6xH-1), 3.96 – 3.77 (m, 11H, 6xH-4, 2.5xH-6), 3.64 – 3.18 (m, 13H, 6xH-5, 3.5xH-6), 
1.15 – 1.02 (m, 108H, 36xCH3Piv). 13C NMR   (101 MHz, CDCl3) δ 177.9-176.8 (12C), 138.6-137.0 
(7C), 128.6-127.4 (35C), 101.5-100.1 (6C), 75.2, 75.1, 75.09, 74.8, 74.5, 74.4, 74.2, 73.9, 73.7, 73.5, 
73.1, 73.0, 70.3, 69.7, 69.5, 69.4, 67.2, 67.0, 66.3, 61.7, 39.0-38.8 (12C), 27.3-27.2 (36C). 
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)- 4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (3) 
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To a 50 mL flame-dried flask was added 17 (1.2 g, 0.46 mmol) and the 14 (609 mg, 0.59 mmol). The 
mixture was dried azeotropically with toluene (2x25 mL) and subjected to vacuum overnight. It was 
then dissolved in dry CH2Cl2 (20 mL) and dry MeCN (20 mL), cooled to -30 °C, followed by addition 
of NIS (136 mg; 0.61 mmol) and TESOTf (12 mg; 0.05 mmol). The reaction mixture was stirred at 
- 30 °C until TLC revealed full conversion of the donor (1 h). The solution was diluted with CH2Cl2 
(200 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (15:1 toluene/EtOAc) to afford 3 as a white amorphous material. Rf 0.37 (9:1 
toluene/EtOAc). Yield: 1.4 g (87%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -15.7° (c 1.0, CDCl3). 1H NMR (400 MHz, CDCl3) δ 
7.39 – 6.97 (m, 45H), 5.42 – 5.20 (m, 8H, H-21-H-28), 5.02 – 4.90 (m, 8H, H-31-H-38), 4.79 (d, JCH2 
= 11.4 Hz, 1H, 0.5xCH2Bn), 4.76 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2Bn), 4.72 – 4.44 (m, 15H, 7.5xCH2Bn), 
4.40 (d, J = 7.9 Hz, 1H, H-11/2/3/4/5/6), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 4.35 (d, J = 7.8 Hz, 
1H, H-11/2/3/4/5/6), 4.30 – 4.19 (m, 6H, 6xH-1), 4.06 (dd, J6a,6b = 11.1, J5,6a = 6.2 Hz, 1H, H-6a8), 3.99 
(dd, J6a,6b =  11.0, J5,6a = 6.6 Hz, 1H, H-6b8), 3.95 – 3.73 (m, 17H, H-41-H-48, 4.5xH-6), 3.70 (d, JCH2 
= 2.3 Hz, 2H, CH2AcCl), 3.67 – 3.44 (m, 10H, H-51-H-58, H-6), 3.36 (dd, J = 9.3, 5.2 Hz, 1H, 0.5xH-
6), 3.32 – 3.14 (m, 4H, 2xH-6), 1.15 (s, 9H, 3xCH3Bn), 1.08 (dd, 126H, 42xCH3), 1.03 (s, 9H, 
3xCH3Bn). 13C NMR   (101 MHz, CDCl3) δ 177.7-176.6 (16C), 166.6, 138.5, 138.5, 138.5, 138.5, 
138.3, 138.2, 138.1, 137.2, 136.9, 128.5-127.1 (45C), 101.2-101.1 (7C), 99.9, 77.2, 75.2, 75.1, 75.0, 
74.6, 74.3, 74.2, 73.6, 73.5, 73.5, 73.4, 73.0, 72.9, 72.8, 72.8, 72.7, 72.7, 71.8, 70.1, 69.7, 69.6, 69.3, 
69.1, 40.4, 39.0-38.7 (16C), 27.2-27.0 (48C). 
Benzyl 4,6-O-benzylidene-β-D-galactopyranosyl-(1→6)-4-O-benzyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-β-D-galactopyranoside (18) 
To a 50 mL flask was added 11 (500 mg, 0.45 mmol), dioxane (10 mL), and water (10 mL). 
Afterwards, 1 M Bu4NOH in MeOH (4.5 mL, 4.5 mmol) was added and the reaction mixture was 
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stirred at 55 °C, overnight. After completion of the reactions, it was neutralized with amberlite IR-120 
H+ resin. Furthermore it was filtered and concentrated. The product was purified by flash 
chromatography (7% MeOH/DCM) to afford 18 as a white amorphous material. Rf 0.30 (9:1 
DCM/MeOH).Yield: 268 mg (86%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= -35.86° (c 1.1, MeOH). IR (neat, cm-1): 3550, 3100, 
3062, 3029, 2873, 1473, 1364, 1153, 1043.  1H NMR (300 MHz, CD3OD) δ 7.55 – 7.11 (m, 25H), 
5.54 (s, 1H), 4.94-4.88 (m, 1H), 4.77-4.58 (m, 6H), 4.35-3.15 (m, 29H). 13C NMR (75 MHz, CD3OD) 
δ 139.6, 139.6, 139.4, 139.0, 138.3, 129.1, 128.8, 128.7, 128.6, 128.6, 128.5, 128.5, 128.5, 128.4, 
128.4, 128.2, 127.9, 127.8, 127.6, 126.9, 104.5, 104.3, 103.3, 103.9, 103.1, 101.6, 77.2, 77.1, 76.6, 
75.5, 75.9, 74.8, 75.0, 73.9, 72.0, 72.1, 71.3, 71.1, 69.3, 68.9, 68.3, 68.0, 67.2.  
β-D-Galactopyranosyl-(1→6)-β-D-galactopyranosyl-(1→6)-β-D-galactopyranosyl-(1→6)-D-
galactopyranose (19) 
To a 100 mL flame-dried flask under N2-atmosphere was added 18 (222 mg, 0.20 mmol), THF 
(10 mL), and MeOH (30 mL). Further, it was followed by the addition of 10% Pd/C (250 mg), and 
the reaction mixture was stirred for 3 h under H2-atmosphere. Furthermore, water (10 mL) was added, 
and resulting mixture was stirred for 48 h under the same conditions. After the completion of 
reactions, the reaction mixture was filtered through a plug of Celite and concentrated. The product 
was purified by reverse phase chromatography to afford 19 as a pale yellow oil. Yield: 111 mg (84%). [𝜶𝜶]𝑫𝑫𝟐𝟐𝟐𝟐= 8.81° (c 1.1, H2O). IR (neat, cm-1): 3500, 3100, 2895, 2484, 1587, 1383, 1132, 1025. 1H NMR 
(500 MHz, D2O) δ 5.25 (d, J = 3.8 Hz, 1H), 4.58 (d, J = 7.9 Hz, 1H), 4.49-4.40 (m, 4H), 4.26 (dd, J 
= 8.0, 4.3 Hz, 1H), 4.09-3.41 (m, 34H). 13C NMR (50 MHz, D2O) δ 106.0, 105.9, 105.8, 99.1, 77.8, 
76.4, 75.4, 75.2, 74.5, 73.4, 71.9, 71.6, 71.4, 71.3, 70.9, 63.7. 
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